A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is $193.47, with a 24-hour trading volume of $343.76M. The asset's market cap is $300.03B, after moving 0.76% in the last day.
Tokenized AstraZeneca PLC is trading at $95.74, with a tokenized market cap of $718.11K and a 24-hour trading volume of $615.59K. The tokenized asset has moved -1.61% in the past 24 hours.